Status:
COMPLETED
Bevacizumab Intravitreal for Myopic Choroidal Neovascularization
Lead Sponsor:
Instituto de Olhos de Goiania
Conditions:
Myopic Choroidal Neovascularization
Eligibility:
All Genders
21-65 years
Phase:
PHASE4
Brief Summary
To evaluate the clinical results of anti-VEGF intra-vitreal injections (IVT) in CNV secondary to pathologic myopia (PM-CNV).
Detailed Description
Nineteen consecutive patients (19 eyes) with subfoveal PM-CNV, 18 of whom had been unsuccessfully treated with Visudyne PDT, were treated with IVT of 1.25 mg bevacizumab or 0.5mg ranibizumab. ETDRS be...
Eligibility Criteria
Inclusion
- Myopic CNVM,
Exclusion
- Patients with poor compliance
- Patients with uncontrolled diabetes and hypertension or any other medical condition that increase the risk of complications like recent history of Stroke or myocardial infraction (\< one year). (Physician clearance was obtained for all patients).
- Age related macular degeneration with Juxtafoveal and Subfoveal CNVM: Recurrent CNVM following PDT and TTT with IVTA. Patient who could not afford PDT, Macugen or Lucentis which is FDA approved.
- Patients who had undergone major surgery 28 days before, were excluded from the study and it was also suspended prior to elective surgery.
- Refractory macular oedema due to vein occlusion, Pseudophakia, Clinically significant macular oedema (CSME) etc. that affects vision and does not respond adequately to usual treatment methods.
- Proliferative diabetic retinopathy, non-resolving vitreous haemorrhage with PDR.
- Idiopathic CNVM, Inflammatory CNVM and other conditions associated with CNVM.
Key Trial Info
Start Date :
January 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2008
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT00797992
Start Date
January 1 2007
End Date
November 1 2008
Last Update
November 25 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Instituto de Olhos de Goiania
Goiânia, Goiás, Brazil, 74120-050